Related Experiment Video
Updated: Aug 14, 2026

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Matthew J Loza1, Susan Foster, Stephen P Peters
1Department of Internal Medicine, Center for Human Genomics, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.
Abstract:
Although the beta2-adrenergic receptor (beta2AR) is the most extensively characterized G-protein-coupled receptor (GPCR), the effects of beta-agonists on T-cell subtype function remain poorly understood. In contrast to studies suggesting lack of beta2AR expression on type 2 T cells, we demonstrate that type 2 interleukin-13+ (IL-13+) T cells (CD4+ or CD8+) in human peripheral blood lymphocytes (PBLs) can respond directly to beta-agonist, with effects including induction of protein kinase A (PKA) activity and associated inhibition of CD3-stimulated CD25 expression; CD3-stimulated IL-13, interferon-gamma (IFN-gamma), and IL-2 production; and p38 mitogen-activated protein kinase (MAPK) phosphorylation. PGE2 was more efficacious than beta-agonist in activating PKA and inhibiting cytokine production. beta-agonist and PGE2 also inhibited phorbol myristate acetate (PMA) + calcimycin-stimulated IFN-gamma and IL-2 (but not IL-13) production, suggesting that upstream CD3-initiated signaling is not the sole locus of PKA actions. Differential regulation of PMA-stimulated p38, p42/p44, and NF-kappaB explained the capacity of PGE2 and beta-agonist to inhibit IFN-gamma but not IL-13 production. The inhibition of CD3 + CD28-stimulated IL-13 production by both beta-agonist and PGE2 was reversed at low agonist concentrations, resulting in enhanced IL-13, but not IFN-gamma or IL-2, production. These findings identify direct effects of beta2AR activation on T-cell subtypes and suggest a complex role for GPCRs and PKA activity in modulating T-cell functions.
Insights
Beta-agonists directly activate beta2-adrenergic receptors (beta2AR) on T cells, modulating immune responses. This study reveals complex roles for G-protein-coupled receptors (GPCRs) and protein kinase A (PKA) in T-cell subtype function.
Area of Science:
- Immunology
- Cellular Signaling
- Pharmacology
Background:
- The beta2-adrenergic receptor (beta2AR) is a well-studied G-protein-coupled receptor (GPCR).
- The impact of beta-agonists on T-cell subtype function is not fully understood.
- Previous studies suggested a lack of beta2AR expression on type 2 T cells.
Purpose of the Study:
- To investigate the direct effects of beta-agonists on T-cell subtype function.
- To explore the role of beta2AR activation in human peripheral blood lymphocytes (PBLs).
- To elucidate the signaling pathways involved in beta-agonist-mediated T-cell modulation.
Main Methods:
- Analysis of type 2 interleukin-13+ (IL-13+) T cells (CD4+ or CD8+) from human PBLs.
- Measurement of protein kinase A (PKA) activity.
- Assessment of CD25 expression and cytokine production (IL-13, IFN-gamma, IL-2) following stimulation.
- Evaluation of p38 mitogen-activated protein kinase (MAPK) phosphorylation and other signaling pathways (p42/p44, NF-kappaB).
Main Results:
- Type 2 T cells express functional beta2AR, responding to beta-agonists.
- Beta-agonist stimulation induced PKA activity and inhibited CD3-stimulated CD25 expression, IL-13, IFN-gamma, and IL-2 production.
- Prostaglandin E2 (PGE2) was more potent than beta-agonist in PKA activation and cytokine inhibition.
- Differential regulation of signaling pathways explained the selective inhibition of IFN-gamma and IL-13.
- Low concentrations of beta-agonist and PGE2 enhanced IL-13 production, but not IFN-gamma or IL-2.
Conclusions:
- Beta2AR activation has direct effects on T-cell subtypes.
- GPCRs and PKA play complex roles in modulating T-cell functions.
- Findings challenge previous assumptions about beta2AR expression and function in T cells.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antihypertensive Drugs: Types of β-Blockers
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

